News and Resources2024-07-11T15:56:23-05:00

IN THE NEWS

MS & AI with Dr. Chase Spurlock, CEO of IQuity

Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and CEO of IQuity talks about how IQuity is using its expertise in machine learning to [read more...]

IQuity Introduces Healthcare Analytics Platform

Machine learning platform predicts, detects and monitors chronic disease across patient populations. Former WPC Healthcare/Intermedix executives, Ray Guzman and Damian Mingle, named advisors for new platform.

BLOG POSTS

OUR ABSTRACTS

OUR PUBLICATIONS

WEBINARS

Garbage In, Garbage Out: The Importance of End-to-End Quality Control Processes for RNA Biomarker Discovery

Garbage In, Garbage Out: The Importance of End-to-End Quality Control Processes for RNA Biomarker Discovery

Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.

Go to Top